Assessment of Alterations in Red Blood Cell Indices, Platelet Indices, and White Blood Cell Counts in Patients with Long-Standing Type 2 Diabetes Mellitus: A Case-Control Study
International Journal of Current Pharmaceutical Review and Research · 30.06.2026 · 18 (06)
DOI: 10.25258/ijcpr.18.6.35 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.06.2026. Verfasst von Shivanand Dwivedi und 6 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder associated with persistent hyperglycemia and systemic complications. This study evaluated alterations in red blood cell (RBC) indices, platelet indices, and white blood cell (WBC) counts in patients with T2DM of more than 10 years' duration compared to healthy controls.
Methods
This case-control study was conducted over an 18-month period at a tertiary healthcare center in Northern India. A total of 272 patients with long-standing T2DM (>10 years post-diagnosis) and 272 age- and sex-matched healthy controls were enrolled. Complete blood counts and glycemic profiles (HbA1c and fasting plasma glucose) were analyzed. Statistical analysis was executed using SPSS version 24.0.
Results
The study included 272 diabetic patients and 272 controls, mostly aged 40–60 years. Gender distribution differed significantly between groups (p = 0.002). Obesity was more common among diabetics with higher BMI (p < 0.001), along with poor glycaemic control. Significant haematological changes in diabetics included altered RBC count (p = 0.03), RDW (p = 0.04), platelet indices, PDW (p = 0.002) and MPV (p = 0.004) and abnormal WBC counts (p = 0.036). Overall, long-standing diabetes was associated with obesity, hyperglycaemia, and significant blood cell alterations.
Conclusion
Long-standing T2DM is strongly associated with distinct modifications in hematological profiles. The statistical elevations in RDW, MPV, PDW, and leukocyte abnormalities highlight ongoing subtle red cell structural fragility, enhanced thrombotic platelet activation, and sustained low-grade systemic inflammation. Routine monitoring of these simple hematological markers can serve as reliable indicators to gauge cellular risk and prevent vascular complications.
Zitieren
APA
Dwivedi, S., Mittal, D., Kumar, H., Sharma, S., Saxena, S., Shukla, N., & Agarwal, S. (2026). Assessment of Alterations in Red Blood Cell Indices, Platelet Indices, and White Blood Cell Counts in Patients with Long-Standing Type 2 Diabetes Mellitus: A Case-Control Study. International Journal of Current Pharmaceutical Review and Research, 18(06). https://doi.org/10.25258/ijcpr.18.6.35
Vancouver
Dwivedi S, Mittal D, Kumar H, Sharma S, Saxena S, Shukla N, et al. Assessment of Alterations in Red Blood Cell Indices, Platelet Indices, and White Blood Cell Counts in Patients with Long-Standing Type 2 Diabetes Mellitus: A Case-Control Study. International Journal of Current Pharmaceutical Review and Research. 2026;18(06). doi:10.25258/ijcpr.18.6.35
BibTeX
@article{Dwivedi2026,
author = {Dwivedi, Shivanand and Mittal, Deepak and Kumar, Hemant and Sharma, Shubhra and Saxena, Somya and Shukla, Namit and Agarwal, Stuti},
title = {Assessment of Alterations in Red Blood Cell Indices, Platelet Indices, and White Blood Cell Counts in Patients with Long-Standing Type 2 Diabetes Mellitus: A Case-Control Study},
journal = {International Journal of Current Pharmaceutical Review and Research},
year = {2026},
volume = {18},
number = {06},
doi = {10.25258/ijcpr.18.6.35}
}
EUVIMED